- Home
- BNT vs ASND Comparison
BNT vs ASND Comparison
Compare BNT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNT
- ASND
- Stock Information
- Founded
- BNT 2020
- ASND 2006
- Country
- BNT Bermuda
- ASND Denmark
- Employees
- BNT N/A
- ASND N/A
- Industry
- BNT
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- BNT
- ASND Health Care
- Exchange
- BNT Nasdaq
- ASND Nasdaq
- Market Cap
- BNT 14.1B
- ASND 12.0B
- IPO Year
- BNT N/A
- ASND 2015
- Fundamental
- Price
- BNT $46.00
- ASND $200.52
- Analyst Decision
- BNT
- ASND Strong Buy
- Analyst Count
- BNT 0
- ASND 17
- Target Price
- BNT N/A
- ASND $245.76
- AVG Volume (30 Days)
- BNT 22.2K
- ASND 398.1K
- Earning Date
- BNT 11-11-2025
- ASND 11-04-2025
- Dividend Yield
- BNT 0.52%
- ASND N/A
- EPS Growth
- BNT N/A
- ASND N/A
- EPS
- BNT 1.85
- ASND N/A
- Revenue
- BNT $14,371,000,000.00
- ASND $576,332,355.00
- Revenue This Year
- BNT N/A
- ASND $104.61
- Revenue Next Year
- BNT N/A
- ASND $79.42
- P/E Ratio
- BNT $24.86
- ASND N/A
- Revenue Growth
- BNT 57.06
- ASND 54.50
- 52 Week Low
- BNT $29.13
- ASND $118.03
- 52 Week High
- BNT $49.44
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- BNT 29.18
- ASND 45.67
- Support Level
- BNT $45.34
- ASND $199.38
- Resistance Level
- BNT $48.78
- ASND $208.39
- Average True Range (ATR)
- BNT 0.91
- ASND 7.94
- MACD
- BNT 0.54
- ASND -0.92
- Stochastic Oscillator
- BNT 43.72
- ASND 50.89
About BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.